Errors in pharmaceutical analysis and statistical

This chapter has been divided into two different portions, namely (a) Errors in Pharmaceutical Analysis, and (b) Statistical Validation, which will be discussed individually in the following sections ... 

Part—I has three chapters that exclusively deal with General Aspects of pharmaceutical analysis. Chapter 1 focuses on the pharmaceutical chemicals and their respective purity and management. Critical information with regard to description of the finished product, sampling procedures, bioavailability, identification tests, physical constants and miscellaneous characteristics, such as ash values, loss on drying, clarity and color of solution, specific tests, limit tests of metallic and non-metallic impurities, limits of moisture content, volatile and non-volatile matter and lastly residue on ignition have also been dealt with. Each section provides adequate procedural details supported by ample typical examples from the Official Compendia. Chapter 2 embraces the theory and technique of quantitative analysis with specific emphasis on volumetric analysis, volumetric apparatus, their specifications, standardization and utility. It also includes biomedical analytical chemistry, colorimetric assays, theory and assay of biochemicals, such as urea, bilirubin, cholesterol and enzymatic assays, such as alkaline phosphatase, lactate dehydrogenase, salient features of radioimmunoassay and automated methods of chemical analysis. Chapter 3 provides special emphasis on errors in pharmaceutical analysis and their statistical validation. The first aspect is related to errors in pharmaceutical analysis and embodies classification of errors, accuracy, precision and makes... 

Gillings D and Koch G (1991) The application of the principle of intention-to-treat analysis of clinical trials Drug Information Journal, 25, 411-424 Greenwood M (1926) The errors of sampling of the survivorship tables Reports on Public Health and Statistical Subjects, No. 33, Appendix 1. London HMSO Grieve AP (2003) The number needed to treat a useful clinical measure or a case of the Emperor s new clothes Pharmaceutical Statistics, 2, 87-102 Haybittle JL (1971) Repeated assessment of results in clinical trials of cancer treatment British Journal of Radiology, 44, 793-797... 

---